Novartis shareholders approve 100% spinout of Sandoz unit (NVS)
TBE/iStock Editorial via Getty Images Novartis (NYSE:NVS) shareholders have voted for a 100% spinout of the company's generic drug and ...
Thursday, December 26, 2024
Tag: Novartis
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
ipopba Deals and Financings Novartis (NVS) signed a $1 billion agreement to acquire DTx Pharma, a preclinical San-Diego company developing ...
Novartis to acquire US-based Chinook for $3.2 billion upfront By Reuters
© Reuters. FILE PHOTO: The company's logo is seen at the new cell and gene therapy factory of Swiss drugmaker ...
Sandoz spin-off updates, comments on Gilenya generics in focus for Novartis Q3 earnings
Robert Way Swiss pharmaceutical giant Novartis (NYSE:NVS) is scheduled to announce Q3 earnings results on Tuesday, October 25th, before market ...
Novartis to spin off Sandoz
https://www.reuters.com/markets/offers/novartis-spin-off-sandoz-list-it-zurich-2022-08-25/ What are your ideas on Novartis inventory or the long run Sandoz inventory? Do you suppose it's value investing ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.